Nanoodor Particles Deliver Drugs to Central Nervous System via Olfactory Pathway
Advanced Science · 2025
DOI: 10.1002/advs.202408908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Wei Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China. Hauptthemen laut MEDLINE: Drug Delivery Systems, Nanoparticles, Olfactory Pathways, Central Nervous System. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenyang Pharmaceutical University, Fundamental Research Funds for the Central Universities, Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Central nervous system (CNS) disorders confront significant challenges in drug delivery due to the blood–brain barrier (BBB). Inspired by the rapid and precise binding of odor molecules to olfactory receptors (ORs), this research uses thiolated HPMA to construct odor nanoparticles (nanoodors) capable of delivering drugs to the CNS via the olfacto–cerebral pathway to overcome the delivery obstruction. The nanoodor core is used to encapsulate agomelatine (AGO), a CNS‐targeting antidepressant, and the encapsulation efficiency exceeded 80%. A series of thiol‐presenting nanoscale structures with different surface densities of thiol groups are constructed, and the effectiveness positively correlated with the density of thiol groups on their surface. Notably, the nanoodors enable precise brain‐targeted delivery, outperforming commercially available oral formulations in terms of drug accumulation in the brain and antidepressant effects. The study of the nanoodor transport and action mechanisms revealed that after binding to ORs, the nanoodors are rapidly delivered to the brain via the olfactory pathway. Nanoodors, the first design to deliver CNS drugs via the olfactory pathway by mimicking natural smells for the treatment of CNS disorders, are expected to achieve clinical transformation, benefiting human health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning, 110016, P. R. China.
- Institute of Cancer Medicine, Faculty of Medicine, Dalian University of Technology, No.2 Linggong Road, Ganjingzi District, Dalian, Liaoning, 116024, China.
- Second Ward of Bone and Soft Tissue Tumor Surgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, 110042, China.
- The Liaoning Provincial Key Laboratory of Interdisciplinary Research on Gastrointestinal Tumor Combining Medicine with Engineering, Shenyang, Liaoning, 110042, China.
ORCID-Profile: Shenglong Li, Yuling Mao
Förderung
- Shenyang Pharmaceutical University
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Liaoning Province
- Fujian Provincial Key Laboratory of Tumor Biotherapy
- Open Funds of State Key Laboratory of Oncology in South China
Zitieren
APA
Zhang, W., Ji, X., Zhao, Q., Qi, J., Guo, W., Zhang, G., Guan, Y., Li, S., & Mao, Y. (2025). Nanoodor Particles Deliver Drugs to Central Nervous System via Olfactory Pathway. Advanced Science. https://doi.org/10.1002/advs.202408908
Vancouver
Zhang W, Ji X, Zhao Q, Qi J, Guo W, Zhang G, et al. Nanoodor Particles Deliver Drugs to Central Nervous System via Olfactory Pathway. Advanced Science. 2025. doi:10.1002/advs.202408908
BibTeX
@article{Zhang2025,
author = {Zhang, Wei and Ji, Xingwang and Zhao, Qianyanqiu and Qi, Jinyao and Guo, Wen and Zhang, Gaoshuo and Guan, Yujing and Li, Shenglong and Mao, Yuling},
title = {Nanoodor Particles Deliver Drugs to Central Nervous System via Olfactory Pathway},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202408908}
}
EUVIMED